Description

This research segment presents the key highlights from the 2011 Biosimilars and Follow-On Biologics Americas conference, February 28 - March 2, 2011 which covered the new abbreviated pathway for biosimilars and other related issues. The purpose of this study is to provide an overview of the U.S. abbreviated biosimilars pathway, a comparison of the abbreviated pathways for biosimilars and small molecule generics, an overview of biosimilars in other countries, an overview of some key trends that affect the biosimilars market, and intellectual property considerations. This study includes content from interviews conducted with key opinion leaders (KOLs) and company executives.